• Health & Medicine

Three new treatment options approved for NHS use in Scotland

The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland The Scottish Medicines Consortium (SMC) has accepted 3 new cancer treatments for NHS use in Scotland

26 March 2020

• Health & Medicine

Leukaemia and head and neck cancer drugs not approved for NHS use in England

Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England. Leukaemia and head and neck cancer drugs have not been recommended for NHS use in England.

23 January 2020

• Health & Medicine

New treatment option for certain leukaemia patients in Scotland

A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland. A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.

14 August 2019

• Health & Medicine

Three new cancer treatments available for NHS patients in Scotland

A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland. A breast cancer drug and two blood cancer treatments have been recommended for use on the NHS in Scotland.

11 July 2019

• Health & Medicine

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England. Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

19 June 2019

• Health & Medicine

Three cancer drugs cleared for NHS funding in Scotland

Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer. Three cancer drugs have been approved for patients on the NHS in Scotland, including a drug for some patients with advanced liver cancer.

17 April 2019

• Health & Medicine

Leukaemia drug gets initial ‘no’ for NHS in England

Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England. Patients with a specific type of leukaemia will not have access to a new treatment after it failed to win provisional recommendation for NHS use in England.

6 March 2019

• Health & Medicine

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer. Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

13 February 2019

• Health & Medicine

First patient receives CAR T cell therapy on NHS

An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS. An 11-year-old boy became the first NHS patient to receive a personalised blood cancer immunotherapy on the NHS.

31 January 2019

• Personal Stories

Chelsea legend Gianfranco Zola surprises Blues fan and cancer survivor

Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto Gianfranco Zola gave eighteen-year-old Ed Garside the surprise of his life in a special meeting organised by Stand Up To Cancer’s official partner, Hyundai Moto

18 October 2018

• Health & Medicine

‘Cutting edge’ CAR T cell immunotherapy approved in England. But is the NHS ready?

With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments. With two complex CAR T immunotherapies now approved on the NHS in England, we look at how the health service has had to react to these exciting new treatments.

5 October 2018

• Personal Stories

Siblings affected by childhood cancer: ‘I’m so proud of what he’s done and how far he’s come’ – James’s story

James shares the story of his younger brother Max, who was diagnosed with chronic myeloid leukaemia, a type of blood cancer, in May 2003. James shares the story of his younger brother Max, who was diagnosed with chronic myeloid leukaemia, a type of blood cancer, in May 2003.

19 September 2018